Help us improve in just 2 minutes—share your thoughts in our reader survey.
Californians Against the Deceptive RX Proposition
This article is outside of Ballotpedia's coverage scope and does not receive scheduled updates. If you would like to help our coverage scope grow, consider donating to Ballotpedia.
| Californians Against the Deceptive RX Proposition | |
 | |
| Basic facts | |
| Location: | Sacramento, Calif. |
| Top official: | Thomas W. Hiltachk, Treasurer |
| Year founded: | 2015 |
| Website: | Official website |
As of 2019, Californians Against the Deceptive RX Proposition, formerly Californians Against the Misleading RX Measure, was a California ballot measure committee made up of "veterans, doctors, patient advocates, seniors, taxpayers," and members of Pharmaceutical Research and Manufacturers of America (PhRMA), a 501(c)(6) nonprofit business association that represents biopharmaceutical research companies. The group was based in Sacramento, California.[1][2][3]
Background
Californians Against the Deceptive RX Proposition was a California ballot measure committee that was first organized in September 2015 as the Pharmaceutical Research and Manufacturers of America California Initiative Fund. The group changed its name to Californians Against the Misleading RX Measure and later became Californians Against the Deceptive RX Proposition.[3]
According to the organization's website, Californians Against the Deceptive RX Proposition was made up of "veterans, doctors, patient advocates, seniors, taxpayers," and members of Pharmaceutical Research and Manufacturers of America (PhRMA), a 501(c)(6) nonprofit business association that represents biopharmaceutical research companies. The group was the leading backer of the No on Prop 61 campaign, which opposed the 2016 Drug Price Standards Initiative (Proposition 61).[2][4]
Political activity
Ballot measure activity
Californians Against the Deceptive RX Proposition opposed the 2016 Drug Price Standards Initiative (Proposition 61), which proposed to regulate drug prices by requiring state agencies to pay the same prices that the U.S. Department of Veterans Affairs (USDVA) pays for prescription drugs.[3]
"The measure would impose unworkable contracting requirements for some state prescription drug purchases based on prices paid by the U.S. Department of Veterans Affairs (VA)," stated the organization's website. "Independent experts warn the measure could increase state prescription drug costs, while reducing patient access to medicines."[5]
Overview of ballot measure support and opposition
The following table details the ballot measure stances for Californians Against the Deceptive RX Proposition available on Ballotpedia:
| Ballot measure support and opposition for Californians Against the Deceptive RX Proposition | |||
|---|---|---|---|
| Ballot measure | Year | Position | Status |
| California Proposition 61, Drug Price Standards (2016) | 2016 | Opposed[3] |  Defeated
|
Leadership
The following individuals held leadership positions with Californians Against the Deceptive RX Proposition during the 2016 election cycle:[3]
- Thomas W. Hiltachk, Treasurer
- Ashlee N. Titus, Assistant treasurer
- Jeff Bond, Principal officer
Recent news
The link below is to the most recent stories in a Google news search for the terms Californians Against the Deceptive RX Proposition. These results are automatically generated from Google. Ballotpedia does not curate or endorse these articles.
See also
- California Proposition 61, Drug Price Standards (2016)
- California 2016 ballot measures
- Healthcare policy in California
External links
- No on Prop 61 homepage
- No on Prop 61 on Twitter
- No on Prop 61 on Facebook
- Pharmaceutical Research and Manufacturers of America homepage
Footnotes
- ↑ CitizenAudit.org, "Pharmaceutical Research and Manufacturers of America," accessed September 19, 2016
- ↑ 2.0 2.1 No on Prop 61, "Home," accessed September 19, 2016
- ↑ 3.0 3.1 3.2 3.3 3.4 Cal-Access, "Californians Against the Deceptive RX Proposition," accessed September 19, 2016
- ↑ Politifact California, "Big Pharma Not The King Of Ballot Cash In California, But It's Close," April 4, 2016
- ↑ No on Prop 61, "Get the Facts," accessed September 19, 2016
| |||||||
